ADVERTISEMENT

J&J Vax data is positive

JamieDimonsBalls

Hall of Famer
Gold Member
Jun 28, 2015
16,545
17,392
113

Phase III should be done this month

Johnson & Johnson’s one-dose coronavirus vaccine is safe and appears to generate a promising immune response in both young and elderly volunteers, according to trial data published Wednesday in the New England Journal of Medicine.

J&J scientists randomly assigned healthy adults between the ages of 18 and 55 and those 65 and older to receive a high or low dose of its vaccine — called Ad26.COV2.S — or a placebo. Some participants in the 18-to-55 age group were also selected to receive a second dose of the vaccine.
 
Also, from Twatters

blob
 
  • Like
Reactions: twenty02
Some more good COVID news re: Vaccinations


People who have already contracted coronavirus are as protected against reinfection as those who have received the best Covid-19 vaccines, according to a survey of 20,000 UK healthcare workers, the largest study in the world so far.

 
From the same article:

A comparison of infections in the two groups, described in preliminary results released on Thursday, found that prior infection provided at least 83 per cent protection against reinfection. It gave better than 94 per cent protection against symptomatic Covid-19, matching the figures for the most effective Covid-19 vaccines.

Susan Hopkins, PHE senior medical adviser, said she was “strongly encouraged” by the finding that infection gave powerful — though not complete — protection against reinfection for at least five months. “Natural infection looks as good as a vaccine, which is very good news for the population,” she said.
 
ADVERTISEMENT